Text Version |Site map | Contact Us | Temple University | FAQs | Search
Prospective Students | Current Students | Faculty/Preceptors | Alumni

Why Temple School of Pharmacy

Read more...
cGMP Services
cGMP Services
Moulder Center
QA/RA

Faculty & Staff Directory

 

Marc Ilies, Ph.D.

Assistant Professor

 

3307 N. Broad Street

Philadelphia, PA 19140

office Room 517

phone (215) 707-1749

email mailies@temple.edu

Biosketch | CV  | Research | Teaching |  Students | Publications


Dr. Marc A. Ilies was born and educated in Romania, receiving his B.Sc. degree from the University of Bucharest in 1995 and his M.Sc. degree from the same university in 1996, after a research stage at ENSC Lille, France, in the framework of the Francophone Teaching Module. In 1996 he joined Professor Alexandru T. Balaban’s group at the Polytechnic University of Bucharest, receiving his PhD in 2001. From 1997 he was also a faculty in the Department of Chemistry, School of Biotechnologies, University of Agricultural Sciences and Veterinary Medicine in Bucharest. In 2001 he followed Dr. Balaban at Texas A&M University in Galveston, TX, for post-doctoral studies aimed to develop new pyridinium cationic lipids for gene delivery, in close collaboration with the groups of Drs. E. Brad Thompson and Robert Garfield from UTMB Galveston, where he was a visiting scientist. In 2004 Dr. Ilies relocated to University of Pennsylvania for postdoctoral studies towards self-assembling amphiphilic dendrons (with Dr. Virgil Percec), amphiphilic polymers and their supra-molecular assemblies as drug delivery systems in cancer pharmacology (with Drs. Vladimir Muzykantov and Ian Blair).


Since 2007, he has been working as an Assistant Professor in the Department of Pharmaceutical Sciences, School of Pharmacy, Temple University. His research interests fit within the broadly-defined medicinal chemistry/chemical biology of membrane interfaces using pyridinium compounds, being focused on the development of chemical solutions for the efficient and selective delivery of drugs and genes for therapeutic purposes.


Dr. Ilies has published over 50 peer-reviewed scientific papers, reviews, and book chapters, and has co-authored one US patent. His publications were cited over 1000 times, with an H-index of 20 (2013). He also serves in the editorial boards of three medicinal chemistry journals.